Brendan Burke

Partner - Boston

Brendan Burke
Download Media Photo

Contact Information


617.832.7000 Download vCard

Brendan Burke is a partner in the firm’s Business Department. He maintains a diverse business practice, focused on advising entrepreneurs and emerging growth clients on a wide range of corporate matters, including entity formation, founder’s arrangements, angel and venture capital financings, exit strategies, and general corporate governance.

Brendan’s clients include both public and private companies as well as venture capital investors. Brendan works across industries, however he has significant experience representing life sciences, technology and cannabis companies. He also represents entrepreneurs as they develop their business plans and launch their companies.


  • Northeastern University School of Law, J.D., 2013
  • Brown University, B.A., 2007

Representative Experience

  • Represented Columbia Care Inc., a cultivator, manufacturer and provider of cannabis products, in its acquisition of vertically integrated cannabis company Medicine Man Denver, for upfront consideration of $42 million and a potential additional milestone payment in 2022 if certain performance targets are met. 
  • Represented Glympse Bio a biotechnology company advancing the way diseases are understood, tracked and treated in its $46.7 million Series B financing.
  • Represented Ankyra Therapeutics, Inc. a developer of biotechnology therapeutics in its $14.5M.Series A Preferred Stock financing.
  • Represented Lucy Therapeutics a biotech company developing new ways to treat neurological disorders in its Series Seed financing.
  • Represented Amagma which specializes in the discovery and development of antibody therapeutics against inflammatory diseases in its $16.4M Series A deal.
  • Represented OnShape Inc., creators of the first Software as a Service (SaaS) product development platform that unites robust computer aided design (CAD) with powerful data management and collaboration tools, in signing a definitive agreement to sell the business to global technology company PTC Inc. for approximately $470 million.
  • Represented Fiera Comox Partners Inc., an independent investment manager providing innovative investment solutions to a wide range of investors through private global investment strategies in private equity and agriculture, in its acquisition of Vermont-based Sweet Tree Holdings 1, LLC (d/b/a The Maple Guild), the world’s largest producer of organic maple syrup and related products.
  • Represented The Boston Consulting Group, one of the leading global management consulting firms, in its acquisition of assets of world-class digital design lab MAYA Design.
  • Represented L2, Inc., a business intelligence firm that benchmarks the digital performance of consumer brands, in its acquisition by Gartner, Inc. (NYSE: IT), the world’s leading information technology research and advisory company.
  • Represented Mill Road Capital, a private investment firm focused on investing in publicly traded micro-cap companies in the U.S. and Canada, in the going private acquisition of Skullcandy, Inc. (Nasdaq; SKUL), a creator of world-class audio experiences through its Skullcandy and Astro Gaming brands, after a contested process.
  • Represented CloudLock, Inc., an industry leader in cloud security for multiple platforms, in its $300 million cash acquisition by Cisco Systems.
  • Represented Mill Road Capital in its acquisition of Mother’s Market & Kitchen.


  • THE BEST LAWYERS IN AMERICA: Ones to Watch in Corporate Governance and Compliance Law (2020)


  • Boston Bar Association, Member
Add to Bio Folder

Download Bio

Bar Admissions

  • Massachusetts